update: Price target based of 32.32 breakout from bottom pattern.
Sinopharm Group is a profitable Chinese state company with 2 covid-19 vaccines (the first is approved in China) with very strong fundamentals (except debt). Sinopharms stock seems to be near the end of a many years correction, ready to reverse its declining trend. Next follows the stocks mid-term trend chart. Disclaimer The writer of this text is not an...
@HKex Start of Wave 3 with price estimates and time bounded by ellipse ;)
Some may not agree and that is fine ! Think for a moment. Many of us spent a lot of time working in our career, clocking hours after office hours hoping to gain that year end promotion, score that bonus or simply act out of peer pressure. Take a minute to read this article I found. I am of the opinion that having a healthcare sector/company is crucial in...